These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7127279)

  • 21. In vitro evaluation of 1-beta-D-arabinofuranosylcytosine-beta-2'-deoxythioguanosine combination chemotherapy.
    Rao PN; Freireich EJ; Bodey GP; Gottlieb JA; Smith ML
    Cancer Res; 1974 Oct; 34(10):2539-43. PubMed ID: 4472144
    [No Abstract]   [Full Text] [Related]  

  • 22. Cell population size dependency of therapeutic effect of divided dosage of 1-beta-D-arabinofuranosylcytosine.
    Abe I; Sato S
    Gan; 1976 Jun; 67(3):461-4. PubMed ID: 1001871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced radiation lethality in partially synchronized solid mouse tumors.
    Todoroki T; Koike S; Tsunemoto H; Watanabe I
    Cancer Res; 1982 Dec; 42(12):5231-5. PubMed ID: 7139626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time-dose relationships for 5-fluorouracil cytotoxicity against human epithelial cancer cells in vitro.
    Calabro-Jones PM; Byfield JE; Ward JF; Sharp TR
    Cancer Res; 1982 Nov; 42(11):4413-20. PubMed ID: 7127282
    [No Abstract]   [Full Text] [Related]  

  • 25. Quantitation of apoptosis induction by etoposide or hydroxyurea in mouse interleukin 3-dependent lymphoma cells.
    Olmos G; Prieto A; Herráez A; Tejedor MC; Alvarez-Mon M; Diez JC
    In Vivo; 2005; 19(2):455-64. PubMed ID: 15796210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetic evaluation of the effect of hydroxyurea on viability of replicating cultured leukemia L1210 cells.
    Wilkoff LJ; Lloyd HH; Dulmadge EA; Dixon GJ
    J Natl Cancer Inst; 1970 Jan; 44(1):201-9. PubMed ID: 11515031
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
    Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production of N4-succinyl-1-beta-D-arabinofuranosylcytosine, a novel metabolite of N4-behenoyl-1-beta-D-arabinofuranosylcytosine, in mice and its biological significance.
    Oh-ishi J; Kataoka T; Tsukagoshi S; Sakurai Y; Shibukawa M; Kobayashi H
    Cancer Res; 1981 Jun; 41(6):2501-6. PubMed ID: 7237444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydroxyurea, a potential new anti-HIV agent.
    Torres G
    GMHC Treat Issues; 1995 Jan; 9(1):7-9. PubMed ID: 11367381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cystathionine-beta-synthase cDNA transfection alters the sensitivity and metabolism of 1-beta-D-arabinofuranosylcytosine in CCRF-CEM leukemia cells in vitro and in vivo: a model of leukemia in Down syndrome.
    Taub JW; Huang X; Ge Y; Dutcher JA; Stout ML; Mohammad RM; Ravindranath Y; Matherly LH
    Cancer Res; 2000 Nov; 60(22):6421-6. PubMed ID: 11103808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Practical threshold for micronucleated reticulocyte induction observed for low doses of mitomycin C, Ara-C and colchicine.
    Asano N; Torous DK; Tometsko CR; Dertinger SD; Morita T; Hayashi M
    Mutagenesis; 2006 Jan; 21(1):15-20. PubMed ID: 16364928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of cholesterol content on antitumor activity and toxicity of liposome-encapsulated 1-beta-D-arabinofuranosylcytosine in vivo.
    Ganapathi R; Krishan A; Wodinsky I; Zubrod CG; Lesko LJ
    Cancer Res; 1980 Mar; 40(3):630-3. PubMed ID: 7471083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sedimentation of DNA from L1210 cells after treatment with 4'-demethylepipodophyllotoxin-9-(4,6-O-2-thenylidene-beta-D-glucopyranoside) or 1-beta-D-arabinofuranosylcytosine or both drugs.
    Roberts D; Hilliard S; Peck C
    Cancer Res; 1980 Nov; 40(11):4225-31. PubMed ID: 7471063
    [No Abstract]   [Full Text] [Related]  

  • 34. Determinants of sensitivity to 1-beta-D-arabinofuranosylcytosine in HCT 116 and NCI-H630 human colon carcinoma cells.
    Grem JL; Geoffroy F; Politi PM; Cuddy DP; Ross DD; Nguyen D; Steinberg SM; Allegra CJ
    Mol Pharmacol; 1995 Aug; 48(2):305-15. PubMed ID: 7651364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recruitment of quiescent tumor by humoral stimulatory activity: requirements for successful chemotherapy.
    Burke PJ; Karp JE; Vaughan WP; Sanford PL
    Blood Cells; 1982; 8(3):519-33. PubMed ID: 7159763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetic effects of sangivamycin in sarcoma 180 in vitro.
    Ritch PS; Glazer RI; Cunningham RE; Shackney SE
    Cancer Res; 1981 May; 41(5):1784-8. PubMed ID: 7214345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paradoxical effect of cytosine arabinoside on mouse leukemia cell line L1210 cells.
    Nakayama T; Sakamoto S; Sassa S; Suzuki S; Kudo H; Nagasawa H
    Anticancer Res; 2005; 25(1A):157-60. PubMed ID: 15816533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synchronization of L1210 leukemia with hydroxyurea infusion and the effect of subsequent pulse dose chemotherapy.
    Moran RE; Straus MJ
    Cancer Treat Rep; 1980 Jan; 64(1):81-6. PubMed ID: 7379059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complementary antineoplastic activity of the cytosine nucleoside analogues troxacitabine (Troxatyl) and cytarabine in human leukemia cells.
    Bouffard DY; Jolivet J; Leblond L; Hamelin B; Ouellet F; Barbeau S; Richard A; Gourdeau H
    Cancer Chemother Pharmacol; 2003 Dec; 52(6):497-506. PubMed ID: 12955470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential sensitivites of human melanoma cells grown in vitro to arabinosylcytosine.
    Barranco SC; Ho DH; Drewinko B; Romsdahl MM; Humphrey RM
    Cancer Res; 1972 Dec; 32(12):2733-6. PubMed ID: 4644205
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.